Article Correctness Is Author's Responsibility: BrainCool AB completes recruitment in trial for FDA clearance of oral mucositis treatment

(King + Company) BrainCool AB, a world leader in medical cooling, has completed patient recruitment for testing of the Intra-Oral Cooling Device Cooral to Eliminate Oral Mucositis, one of the severest side effects of chemotherapy and radiation cancer treatments, and is on track with its De Novo 510(k) process for Market Registration in the U.S.